BCL2 and ovarian cancer: To examine this possibility, we collected lymphocytes from the peripheral blood of 12 ovarian cancer patients (seven samples with the reference sequence and five samples with the heterozygous 21 T > C variant), extracted RNA and quantified BCL2 mRNA levels, and compared them to actin using qRT-PCR.